https://www.selleckchem.com/pr....oducts/lenalidomide-
As digital health tools such as smartphone apps evolve and enter clinical use, questions regarding their value must be addressed. Although there are scarce generalizable data on the value of health apps given their nascency and diverse use cases, it is possible to estimate the economic value of the clinical improvement they bring to patients using a quality-adjusted life-year (QALY)-based approach and generalized values from existing literature. This paper aims to provide a patient-centered framework for assessing the economi
Like
Comment
Share
